Literature DB >> 12230975

OcaB is required for normal transcription and V(D)J recombination of a subset of immunoglobulin kappa genes.

Rafael Casellas1, Mila Jankovic, Gesa Meyer, Anna Gazumyan, Yan Luo, Robert Roeder, Michel Nussenzweig.   

Abstract

OcaB, a transcriptional coactivator also known as Bob-1 or OBF-1, was isolated on the basis of its ability to enhance transcription of immunoglobulin (Ig) genes in vitro. Paradoxically, OcaB(-/-) mice showed no apparent deficiency in Ig gene transcription, only cellular immune defects including absence of germinal centers (GC) and decreased numbers of immature B cells; the genes targeted by OcaB were not determined. Here we report that OcaB is essential for V(D)J recombination of a subset of Igkappa genes. We show that OcaB modulates recombination by directly enhancing Igkappa gene transcription in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12230975     DOI: 10.1016/s0092-8674(02)00911-x

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  27 in total

1.  T cell receptor (TCR) alpha/delta locus enhancer identity and position are critical for the assembly of TCR delta and alpha variable region genes.

Authors:  Craig H Bassing; Robert E Tillman; Barbara B Woodman; David Canty; Robert J Monroe; Barry P Sleckman; Frederick W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

2.  B cell development and immunoglobulin transcription in Oct-1-deficient mice.

Authors:  Victoria E H Wang; Dean Tantin; Jianzhu Chen; Phillip A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-04       Impact factor: 11.205

Review 3.  B Lymphocytes and Adipose Tissue Inflammation.

Authors:  Prasad Srikakulapu; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-03-05       Impact factor: 8.311

4.  A multifunctional element in the mouse Igκ locus that specifies repertoire and Ig loci subnuclear location.

Authors:  Yougui Xiang; Xiaorong Zhou; Susannah L Hewitt; Jane A Skok; William T Garrard
Journal:  J Immunol       Date:  2011-03-25       Impact factor: 5.422

5.  Long-range interactions between three transcriptional enhancers, active Vkappa gene promoters, and a 3' boundary sequence spanning 46 kilobases.

Authors:  Zhe Liu; William T Garrard
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

6.  Transgenic mice expressing dominant-negative bright exhibit defects in B1 B cells.

Authors:  Jamee C Nixon; Scott Ferrell; Cathrine Miner; Athenia L Oldham; Ute Hochgeschwender; Carol F Webb
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

7.  Cell-type-specific function of BCL9 involves a transcriptional activation domain that synergizes with beta-catenin.

Authors:  Claudio Sustmann; Henrik Flach; Hanna Ebert; Quinn Eastman; Rudolf Grosschedl
Journal:  Mol Cell Biol       Date:  2008-03-17       Impact factor: 4.272

8.  Interactome maps of mouse gene regulatory domains reveal basic principles of transcriptional regulation.

Authors:  Kyong-Rim Kieffer-Kwon; Zhonghui Tang; Ewy Mathe; Jason Qian; Myong-Hee Sung; Guoliang Li; Wolfgang Resch; Songjoon Baek; Nathanael Pruett; Lars Grøntved; Laura Vian; Steevenson Nelson; Hossein Zare; Ofir Hakim; Deepak Reyon; Arito Yamane; Hirotaka Nakahashi; Alexander L Kovalchuk; Jizhong Zou; J Keith Joung; Vittorio Sartorelli; Chia-Lin Wei; Xiaoan Ruan; Gordon L Hager; Yijun Ruan; Rafael Casellas
Journal:  Cell       Date:  2013-12-19       Impact factor: 41.582

9.  Embryonic lethality, decreased erythropoiesis, and defective octamer-dependent promoter activation in Oct-1-deficient mice.

Authors:  Victoria E H Wang; Tara Schmidt; Jianzhu Chen; Phillip A Sharp; Dean Tantin
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

10.  Enforced expression of the transcriptional coactivator OBF1 impairs B cell differentiation at the earliest stage of development.

Authors:  Alain Bordon; Nabil Bosco; Camille Du Roure; Boris Bartholdy; Hubertus Kohler; Gabriele Matthias; Antonius G Rolink; Patrick Matthias
Journal:  PLoS One       Date:  2008-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.